Ewa Niżankowska

1.4k total citations
15 papers, 1.0k citations indexed

About

Ewa Niżankowska is a scholar working on Physiology, Pharmacology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ewa Niżankowska has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Physiology, 11 papers in Pharmacology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ewa Niżankowska's work include Asthma and respiratory diseases (12 papers), Drug-Induced Adverse Reactions (10 papers) and Respiratory and Cough-Related Research (8 papers). Ewa Niżankowska is often cited by papers focused on Asthma and respiratory diseases (12 papers), Drug-Induced Adverse Reactions (10 papers) and Respiratory and Cough-Related Research (8 papers). Ewa Niżankowska collaborates with scholars based in Poland, Sweden and United States. Ewa Niżankowska's co-authors include Andrzej Szczeklik, A Szczeklik, Grażyna Bochenek, Lucyna Mastalerz, Barbro Dahlén, Sven‐Erik Dahlén, Krzysztof Nagraba, Maria Kumlin, Mamert Milewski and Linda J. Swanson and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Allergy and Clinical Immunology and Biochemical Pharmacology.

In The Last Decade

Ewa Niżankowska

13 papers receiving 979 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ewa Niżankowska Poland	12	853	499	436	236	101	15	1.0k
Katharine M. Woessner United States	18	621 0.7×	519 1.0×	257 0.6×	289 1.2×	268 2.7×	35	1.1k
María Pilar Berges‐Gimeno Spain	13	601 0.7×	792 1.6×	301 0.7×	193 0.8×	152 1.5×	18	1.1k
G Czerniawska-Mysik Poland	11	594 0.7×	673 1.3×	166 0.4×	150 0.6×	34 0.3×	27	1.0k
Monika Świerczyńska Poland	5	328 0.4×	354 0.7×	133 0.3×	96 0.4×	59 0.6×	9	510
G. Canto Spain	24	674 0.8×	1.0k 2.0×	93 0.2×	686 2.9×	7 0.1×	49	1.5k
J. F. Costello United Kingdom	11	167 0.2×	43 0.1×	187 0.4×	35 0.1×	3 0.0×	14	396
Munehiko Morishita Japan	12	234 0.3×	50 0.1×	177 0.4×	8 0.0×	4 0.0×	22	430
Kota Nishihama Japan	13	95 0.1×	12 0.0×	145 0.3×	15 0.1×	5 0.0×	40	396
P Leiberman United Kingdom	8	41 0.0×	93 0.2×	63 0.1×	6 0.0×	3 0.0×	10	445
Mari Hikichi Japan	9	117 0.1×	13 0.0×	263 0.6×	13 0.1×	5 0.0×	14	458

Countries citing papers authored by Ewa Niżankowska

Since Specialization

Citations

This map shows the geographic impact of Ewa Niżankowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewa Niżankowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewa Niżankowska more than expected).

Fields of papers citing papers by Ewa Niżankowska

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ewa Niżankowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewa Niżankowska. The network helps show where Ewa Niżankowska may publish in the future.

Co-authorship network of co-authors of Ewa Niżankowska

This figure shows the co-authorship network connecting the top 25 collaborators of Ewa Niżankowska. A scholar is included among the top collaborators of Ewa Niżankowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewa Niżankowska. Ewa Niżankowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Stręk, Paweł, et al.. (2004). [Functional assessment of posterior cordotomy in patients with bilateral vocal fold paralysis].. PubMed. 58(3). 451–7. 1 indexed citations

2.

Gyllfors, Pär, Grażyna Bochenek, Maria Kumlin, et al.. (2003). Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. Journal of Allergy and Clinical Immunology. 111(5). 1116–1121. 101 indexed citations

3.

Bochenek, Grażyna, Krzysztof Nagraba, Ewa Niżankowska, & Andrzej Szczeklik. (2003). A controlled study of 9α,11β-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. Journal of Allergy and Clinical Immunology. 111(4). 743–749. 130 indexed citations

4.

Dahlén, Sven‐Erik, Kerstin Malmström, Ewa Niżankowska, et al.. (2002). Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist: A Randomized, Double-Blind, Placebo-Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 165(1). 9–14. 236 indexed citations

5.

Szczeklik, A, Ewa Niżankowska, Lucyna Mastalerz, & Zsuzsanna Szabó. (2002). Analgesics and Asthma. American Journal of Therapeutics. 9(3). 233–243. 13 indexed citations

6.

Szczeklik, A, Ewa Niżankowska, Marek Sanak, & Monika Świerczyńska. (2001). Aspirin-induced rhinitis and asthma. Current Opinion in Allergy and Clinical Immunology. 1(1). 27–33. 23 indexed citations

7.

Szczeklik, A, Ewa Niżankowska, Marek Sanak, & Monika Świerczyńska. (2001). Aspirin-induced rhinitis and asthma. Current Opinion in Allergy and Clinical Immunology. 1(1). 27–33. 19 indexed citations

8.

Dahlén, Barbro, Ewa Niżankowska, A Szczeklik, et al.. (1998). Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics. American Journal of Respiratory and Critical Care Medicine. 157(4). 1187–1194. 291 indexed citations

9.

Szczeklik, Andrzej, Ryszard Dworski, Lucyna Mastalerz, et al.. (1998). Salmeterol Prevents Aspirin-induced Attacks of Asthma and Interferes with Eicosanoid Metabolism. American Journal of Respiratory and Critical Care Medicine. 158(4). 1168–1172. 30 indexed citations

10.

Milewski, Mamert, Lucyna Mastalerz, Ewa Niżankowska, & Andrzej Szczeklik. (1998). Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. Journal of Allergy and Clinical Immunology. 101(5). 581–586. 114 indexed citations

11.

Niżankowska, Ewa, et al.. (1996). Cytokine production in human and rat macrophages and dicatechol rooperol and esters. Biochemical Pharmacology. 52(7). 991–998. 17 indexed citations

12.

Niżankowska, Ewa, et al.. (1985). Bronchodilatory properties of 2-decarboxy-2-hydroxymethyl prostaglandin E1. Prostaglandins. 29(3). 349–362. 5 indexed citations

13.

Szczeklik, Andrzej, et al.. (1985). Hydrocortisone and airflow impairment in aspirin-induced asthma. Journal of Allergy and Clinical Immunology. 76(4). 530–536. 41 indexed citations

14.

Szczeklik, A & Ewa Niżankowska. (1983). Asthma improved by aspirin-like drugs. British Journal of Diseases of the Chest. 77(2). 153–158. 16 indexed citations

15.

Szczeklik, Andrzej, et al.. (1974). Serum alpha 1-antitrypsin in bronchial asthma.. PubMed. 109(4). 487–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact